Addition of anacetrapib to statins lowers coronary events in ASCVD: REVEAL trial
UK: E Sammons, University of Oxford, Oxford, UK, and colleagues have found in a randomized controlled trial REVEAL that addition of cholesteryl ester transfer protein inhibitor therapy anacetrapib to...
Source: medicaldialogues.in